loadpatents
name:-0.052516937255859
name:-0.012625932693481
name:-0.015836000442505
Cheng; Yun-Xing Patent Filings

Cheng; Yun-Xing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cheng; Yun-Xing.The latest application filed is for "tetracyclic oxazepine compounds and uses thereof".

Company Profile
14.11.45
  • Cheng; Yun-Xing - Beijing CN
  • Cheng; Yun-Xing - Montreal CA
  • Cheng; Yun-Xing - St. Laurent CA
  • Cheng; Yun-Xing - Saint Laurent CA
  • Cheng; Yun-Xing - Ville Saint-Laurent CA
  • Cheng, Yun-Xing - Quebec CA
  • Cheng, Yun-Xing - Dollard-des-Ormeaux CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrazolopyrimidine inhibitors of JAK kinases and uses thereof
Grant 11,453,671 - Zak , et al. September 27, 2
2022-09-27
Tetracyclic Oxazepine Compounds And Uses Thereof
App 20220281893 - GAZZARD; Lewis J. ;   et al.
2022-09-08
Inhaled Powder Formulations
App 20220204517 - Cheng; Yun-Xing ;   et al.
2022-06-30
Pyrazolopyrimidine Aryl Ether Inhibitors Of Jak Kinases And Uses Thereof
App 20220106322 - Zak; Mark Edward ;   et al.
2022-04-07
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20220024945 - ZAK; Mark ;   et al.
2022-01-27
Pyrazolopyrimidine compounds and methods of use thereof
Grant 11,155,557 - Romero , et al. October 26, 2
2021-10-26
Therapeutic Compounds, Compositions And Methods Of Use Thereof
App 20210179564 - Crawford; James John ;   et al.
2021-06-17
Pyrazolopyrimidine Sulfone Inhibitors Of Jak Kinases And Uses Thereof
App 20200399275 - Zak; Mark Edward ;   et al.
2020-12-24
Tetrazole-substituted Pyrazolopyrimidine Inhibitors Of Jak Kinases And Uses Thereof
App 20200399274 - Zak; Mark Edward ;   et al.
2020-12-24
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20200352951 - ZAK; Mark ;   et al.
2020-11-12
Pyrazolopyrimidine Compounds As Jak Inhibitors
App 20200339604 - ZAK; Mark ;   et al.
2020-10-29
8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl Compounds, Compositions And Methods Of Use Thereof
App 20200270248 - GOODACRE; Simon Charles ;   et al.
2020-08-27
Inhaled Powder Formulations
App 20200165260 - Cheng; Yun-Xing ;   et al.
2020-05-28
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20200062779 - ZAK; Mark ;   et al.
2020-02-27
Pyrazolopyrimidine Compounds And Methods Of Use Thereof
App 20190345165 - ROMERO; F. Anthony ;   et al.
2019-11-14
Triazolopyridine Compounds And Methods Of Use Thereof
App 20190337946 - Goodacre; Simon Charles ;   et al.
2019-11-07
5-chloro-2-difluoromethoxyphenyl Pyrazolopyrimidine Compounds,compositions And Methods Of Use Thereof
App 20190322661 - Zak; Mark Edward ;   et al.
2019-10-24
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20190240227 - ZAK; Mark ;   et al.
2019-08-08
Triazolopyridine Compounds, Compositions And Methods Of Use Thereof
App 20190233441 - Ray; Nicholas C. ;   et al.
2019-08-01
8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl Compounds, Compositions And Methods Of Use Thereof
App 20190202822 - GOODACRE; Simon Charles ;   et al.
2019-07-04
Therapeutic compounds and compositions, and methods of use thereof
Grant 10,307,426 - Zak , et al.
2019-06-04
Therapeutic Compounds, Compositions And Methods Of Use Thereof
App 20190071404 - Crawford; James John ;   et al.
2019-03-07
Therapeutic compounds, compositions and methods of use thereof
Grant 10,189,836 - Cheng , et al. Ja
2019-01-29
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20180334465 - ZAK; Mark ;   et al.
2018-11-22
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20180333416 - ZAK; Mark ;   et al.
2018-11-22
Triazolopyridine Compounds And Methods Of Use Thereof
App 20180327402 - Goodacre; Simon Charles ;   et al.
2018-11-15
5-chloro-2-difluoromethoxyphenyl Pyrazolopyrimidine Compounds,compositions And Methods Of Use Thereof
App 20180305355 - Zak; Mark Edward ;   et al.
2018-10-25
Triazolopyridine Compounds, Compositions And Methods Of Use Thereof
App 20180298033 - Ray; Nicholas C. ;   et al.
2018-10-18
Therapeutic Compounds, Compositions And Methods Of Use Thereof
App 20180297997 - Cheng; Yun-Xing ;   et al.
2018-10-18
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20180265515 - Cheng; Yun-Xing ;   et al.
2018-09-20
Triazolopyridine Compounds And Methods Of Use Thereof
App 20180086757 - Goodacre; Simon Charles ;   et al.
2018-03-29
Triazolopyridine compounds, compositions and methods of use thereof
Grant 9,873,709 - Ray , et al. January 23, 2
2018-01-23
Triazolopyridine Compounds, Compositions And Methods Of Use Thereof
App 20170226132 - Ray; Nicholas C. ;   et al.
2017-08-10
5-chloro-2-difluoromethoxyphenyl Pyrazolopyrimidine Compounds,compositions And Methods Of Use Thereof
App 20170145020 - Zak; Mark Edward ;   et al.
2017-05-25
5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof
Grant 9,604,984 - Zak , et al. March 28, 2
2017-03-28
5-chloro-2-difluoromethoxyphenyl Pyrazolopyrimidine Compounds,compositions And Methods Of Use Thereof
App 20160237086 - ZAK; Mark Edward ;   et al.
2016-08-18
Triazolopyridine Compounds, Compositions And Methods Of Use Thereof
App 20160185780 - RAY; Nicholas C. ;   et al.
2016-06-30
5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof
Grant 9,346,815 - Zak , et al. May 24, 2
2016-05-24
5-chloro-2-difluoromethoxyphenyl Pyrazolopyrimidine Compounds, Compositions And Methods Of Use Thereof
App 20150336962 - Zak; Mark Edward ;   et al.
2015-11-26
Piperidine derivatives and their use as muscarinic receptor modulators
Grant 8,119,661 - Cheng , et al. February 21, 2
2012-02-21
Compounds
Grant 7,956,069 - Cheng , et al. June 7, 2
2011-06-07
Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia
App 20100173941 - Cheng; Yun-Xing ;   et al.
2010-07-08
Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia
App 20100173935 - Cheng; Yun-Xing ;   et al.
2010-07-08
Novel Tetrahydro-1H-Pyrido[4,3-b] Indole Derivatives as CB1 Receptor Ligands
App 20100113502 - Cheng; Yun-Xing ;   et al.
2010-05-06
Novel Compounds-300
App 20090275574 - Cheng; Yun-Xing ;   et al.
2009-11-05
Muscarinic Receptor Agonists, Compositions, Methods Of Treatment Thereof, And Processes For Preparation Thereof 177
App 20090221567 - Cheng; Yun-Xing ;   et al.
2009-09-03
New compounds 966
App 20090076078 - Cheng; Yun-Xing ;   et al.
2009-03-19
Novel Compounds
App 20070287695 - Cheng; Yun-Xing ;   et al.
2007-12-13
Novel Compounds
App 20070259888 - Cheng; Yun-Xing ;   et al.
2007-11-08
Novel compounds
App 20060135554 - Cheng; Yun-Xing ;   et al.
2006-06-22
Compounds
Grant 7,030,139 - Cheng , et al. April 18, 2
2006-04-18
Therapeutic heterocycles
App 20050245503 - Cheng, Yun-Xing ;   et al.
2005-11-03
Method for the treatment or prevention of Flavivirus infections using nucleoside analogues
App 20040248844 - Ismaili, Hicham Moulay Alaoui ;   et al.
2004-12-09
Method for the treatment or prevention of flavivirus infections using nucleoside analogues
Grant 6,784,161 - Ismaili , et al. August 31, 2
2004-08-31
Novel compounds
App 20040116465 - Cheng, Yun-Xing ;   et al.
2004-06-17
Method for the treatment or prevention of flavivirus infections using nucleoside analogues
App 20020019363 - Ismaili, Hicham Moulay Alaoui ;   et al.
2002-02-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed